Compare American Homes 4 Rent Class A (AMH) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Homes 4 Rent Class A vs Davita Inc — how do they compare? American Homes 4 Rent Class A trades at $33.92 (market cap $12.28B), while Davita Inc trades at $179.02 (market cap $11.38B). The key difference: American Homes 4 Rent Class A and Davita Inc are close in size by market cap, and American Homes 4 Rent Class A pays a 3.87% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| AMH | DVA | |
|---|---|---|
Market Cap | $12.28B | $11.38B |
Sector | Real Estate | Health |
52-Week High | $35.82 | $240.96 |
52-Week Low | $27.38 | $103.87 |
Enterprise Value | $17.35B | $24.10B |
Dividend Yield | 3.87% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
